Development of adaptive designs, including adaptive designs in confirmatory clinical trials and Bayesian adaptive designs in early-stage clinical trials, and development of multiplicity adjustments for confirmatory clinical trials with multiple objectives, development of subgroup analysis and identification strategies in Phase II and III trials